Novo Nordisk Walks Away from $10 Billion Biotech Deal — Genius Move or Risky Gamble?
Novo Nordisk Shocks the Market Novo Nordisk, the Danish pharmaceutical giant, stunned investors by pulling out of a $10 billion
Adding {{itemName}} to cart
Added {{itemName}} to cart
